Skip to main navigation Skip to search Skip to main content

PROTOCOL 030: BLOCKADE OF THE GP IIB/IIIA RECEPTOR TO AVOID VASCULAR OCCLUSION (BRAVO) SB-214857

Project: Research

Project Details

StatusFinished
Effective start/end date03/1/99 → 12/31/02

Funding

  • Smithkline Beecham Pharmaceuticals: $11,962.00